Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection

Antiblastic drugs-induced cardiomyopathy remains a relevant cause of morbidity and mortality, during and after chemotherapy, despite the progression in protective therapy against cardiovascular diseases and myocardial function. In the last few decades, many groups of researchers have focused their a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazzini, Luca, Caggiari, Ludovica, Deidda, Martino, Onnis, Carlotta, Saba, Luca, Mercuro, Giuseppe, Cadeddu Dessalvi, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693331/
https://www.ncbi.nlm.nih.gov/pubmed/36431222
http://dx.doi.org/10.3390/jcm11226745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693331/
https://www.ncbi.nlm.nih.gov/pubmed/36431222
http://dx.doi.org/10.3390/jcm11226745

Ejemplares similares